RASD2 and Huntington disease: Rhes resembles Rheb, a known activator of mTOR [22] and in a cell culture model mHTT can promote nutrient-induced mTORC1 activity via Rheb [23], raising the possibility that dysregulation of striatal mTORC1 signaling via Rhes and Rheb could affect HD [24].